A vitamin B3 supplement for moderate kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if the supplement improves kidney function or slows down the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate chronic kidney disease (not yet needing dialysis).
- You are not pregnant.
- You do not have advanced liver disease or HIV.
- You can get around your home without help (a cane or walker is fine).
- You are not taking immune-suppressing drugs, and you have not had a recent heart attack or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a vitamin B3 supplement (nicotinamide) before, during, and after heart surgery can help protect the kidneys from injury. If you are having heart surgery and have a higher risk of kidney damage, this treatment might reduce that risk.
This study tests whether nicotinamide riboside (a B-vitamin supplement) can help people with combined pulmonary hypertension—a condition where blood pressure in the lungs is too high. The researchers want to understand how this supplement affects the body's energy metabolism and whether it might reduce symptoms and improve heart function.
This study tests whether a daily supplement (nicotinamide riboside, a form of vitamin B3) can slow the progression of early Alzheimer's disease over two years. It is a randomized, double-blind trial, meaning half the participants will get the supplement and half will get a placebo (a pill with no active ingredient), and neither you nor the doctors will know which you are getting.
This trial tests a vitamin B3 supplement (nicotinamide riboside) combined with a walking program to see if it helps improve walking ability in people with peripheral artery disease (blocked leg arteries). If you qualify, you may get the supplement or a placebo along with supervised exercise.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.
This trial tests if a vitamin B3-like supplement, nicotinamide riboside, can help people with early to mid-stage Huntington's disease. You will be randomly assigned to take the supplement or a placebo to see if it slows the disease.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.